CP-TM
GHRH(1-44) with Hexenoic Acid Modification
Brief Description
Full-length 44-amino acid GHRH analog with a trans-3-hexenoic acid modification that improves stability and receptor binding. One of the most extensively studied GHRH analogs in published literature, with research focused on visceral adipose tissue, lipodystrophy models, IGF-1 axis modulation, and cognitive function in aging populations. For research use only — not for human consumption.
Testing Archive
Review current and previous batch records, including COAs and supporting third-party testing documentation.
Browse Testing Archive →Product Details
Form
Lyophilized powder
Compound Specifications
CAS
804475-66-9
MW
5135.93 g/mol
Formula
C222H370N72O67S1
Sequence
Hexenoic acid-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Storage & Handling
Storage: Store lyophilized at -20°C.
For laboratory research use only — not for human consumption